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Abstract

Author Manuscript

Dendritic spine pathology is a key feature of several neuropsychiatric disorders. The Rac1 guanine
nucleotide exchange factor kalirin-7 is critical for spine morphogenesis on cortical pyramidal
neurons. Here we identify a rare coding variant in the KALRN gene region that encodes the
catalytic domain, in a schizophrenia patient and his sibling with major depressive disorder. The
D1338N substitution significantly diminished the protein's ability catalyze the activation of Rac1.
Contrary to wild-type kalirin-7, kalirin-7-D1338N failed to increase spine size and density. Both
subjects carrying the polymorphism displayed reduced cortical volume in the superior temporal
sulcus (STS), a region implicated in schizophrenia. Consistent with this, mice with reduced kalirin
expression showed reduced neuropil volume in the rodent homolog of the STS. These data suggest
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that single amino acid changes in proteins involved in dendritic spine function can have significant
effects on the structure and function of the cerebral cortex.
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Introduction

Author Manuscript

In the mammalian forebrain, most excitatory synapses are located on dendritic spines, small
protrusions of dendrites1. Spine morphology modulates synaptic properties and the ability to
undergo plasticity2, 3. Spine plasticity driven by changes in synaptic activity contributes to
the remodeling of neural circuits during postnatal development, including experiencedependent plasticity which occurs throughout life. Spine enlargement parallels various forms
of potentiation, including long-term potentiation (LTP), whereas long-term depression
(LTD) seems associated with spine shrinkage4. Accordingly, spines can undergo
morphological changes in live animals following changes in sensory input, and during social
interactions, stress, environmental enrichment, learning and other behavioral conditions5.

Author Manuscript

Abnormal synaptic connectivity is a well-established characteristic of several psychiatric
disorders, including schizophrenia, but the exact molecular mechanisms underlying synaptic
pathogenesis are not known6, 7. Mounting evidence indicating that known schizophrenia
susceptibility genes regulate spines strongly reinforces the hypothesis that perturbations in
the molecular pathways underlying spine plasticity are deeply involved in the development
and progression of schizophrenia7. Because dendrites and spines make up a significant
fraction of the cortical neuropil, it has been hypothesized that changes in dendrite and spine
number and morphology may lead to alterations in cortical thickness measures, a finding
reported in several mental disorders, including schizophrenia8.

Author Manuscript

Changes in the actin cytoskeleton are heavily implicated in the morphological alteration of
spines and are controlled by proteins of the small GTPase family9. These proteins serve as
molecular switches that fluctuate between GTP-bound active and GDP-bound inactive
states, and are controlled by guanine nucleotide exchange factors (GEFs) and GTPase
activating proteins (GAPs)10. One of these small GTPase regulators, the Rac-GEF
commonly known as kalirin-7 but sometimes referred to as Duo, has been identified as both
playing a critical role in spine morphogenesis and associated with increased psychiatric
risk7, 11. Kalirin-7, encoded by the human KALRN gene and the rodent Kalrn gene, is the
most highly expressed kalirin protein isoform in the adult rodent brain, with its highest
expression levels in the cerebral cortex and hippocampus12, 13. It is primarily localized to
spines, and its expression levels rise during a period corresponding to that of
synaptogenesis12, 14. Kalirin-7 catalyzes the activation of Rac1, thereby allowing it to bind
to p21-activated kinase (PAK), which in turn facilitates actin remodeling15, 16.
Overexpression of kalirin-7 results in increased spine number15, and neurons in which
kalirin-7 has been knocked down display reductions in spine density17. Kalirin-7 is also
required for NMDA receptor-dependent structural plasticity and concomitant increases in
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synaptic AMPA receptor expression17, 18 and interacts with the products of schizophrenia
susceptibility genes DISC119, NRG1, and ERBB420 to regulate spine and dendrite plasticity.
Kalrn knockout mice display a periadolescent reduction in cortical dendritic spine number
and reduced dendritic complexity, as well as deficits in working memory that emerge in
adolescence18, 21. KALRN has been associated with schizophrenia risk through resequencing and association analysis22 and post-mortem analyses of patients' cortical
KALRN mRNA and protein levels23, 24.

Author Manuscript

Recent large scale studies revealed that rare sequence variants, such as copy number
variations and exonic mutations in glutamatergic synaptic plasticity genes are enriched in
subjects with schizophrenia25, 26. However, functional analyses of such sequence variants,
especially exonic mutations, present in human subjects in synaptic plasticity genes have not
been extensively performed. In addition, the relationship between such molecular and
cellular variations and macroscopic brain morphometric phenotypes has not been examined.
As an initial step in this direction, we sought to identify coding and potentially functionally
important variants in KALRN in human subjects, assess the functional impact of such
variations, and explore neuromorphometric parameters in carrier subjects. We thus
sequenced specifically in the region that codes for the kalirin protein's Rac1-GEF catalytic
domain. We identified one such variant which significantly impaired protein function and
neuronal morphology. Interestingly, the subjects carrying this variant displayed reduced
cortical thickness in the caudal portion of the superior temporal sulcus. Consistent with this,
mice lacking the kalrn gene show reduced cortical thickness, suggesting a potential link
between molecular and cellular alterations and macroscopic neuromorphological
phenotypes.

Author Manuscript

Results
Identification of KALRN sequence variants

Author Manuscript

We screened for missense sequence variants in exons 23-28 of human KALRN (Figure 1a),
which encode the Dbl homology (DH) portion of its gene products' Rac1-GEF enzymatic
domain, in a cohort of well-characterized schizophrenia subjects. Sequencing and automated
indel/SNP analysis of these exons led to the identification of a rare coding variant,
NC_000003. 12:g.124462620G>A (NP_001019831.2:p.D1338N), located in the Rac1-GEF
domain of KALRN in a single subject with schizophrenia (KAL-SCZ) (Figure 1b;
Supplementary Table 1). This initial screen was followed by a second screen for the variant
in siblings and non-diseased controls (Supplementary Table 2). The only carrier for the
variant identified in this screen was a sibling of KAL-SCZ (KAL-SIB), who while not
schizophrenic, had been diagnosed with major depressive disorder and alcohol and cocaine
dependence. This known minor allele (rs139954729) is predicted by PolyPhen27 to be
probably damaging, with a score of 0.981 (sensitivity: 0.75; specificity: 0.96). It was not
found in European ancestry subjects in a large exome sequencing data set, NHLBI GO
Exome Sequencing Project (ESP) (n=4300; http://evs.gs.washington.edu/EVS/). It is also
found in African American subjects (n=4404 chromosomes), but with a very low population
frequency (0.044%). We could not establish the statistical evidence for the association with
schizophrenia due to the limited sample size and incidence of the variant. Nevertheless, we
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sought to determine whether it would lead to cellular phenotypes, given that the variant was
identified in a schizophrenia patient and his sibling with other neuropsychiatric disorders, as
well as its low population frequency and the predicted deleterious property.
Biochemical characterization of the D1338N variant

Author Manuscript

The p.D1338 residue is located in the Rac1-GEF domain of KALRN, and is highly
conserved across species in related protein family members, so we hypothesized that a
substitution that changes the charge from an acidic to a slightly basic residue in this domain
is likely to affect protein function. To determine whether this would be the case, we
transfected hEK-293 cells with a cDNA homologous to either the human major allele
(referred to hereafter as “wildtype kalirin-7”) or D1338N kalirin-7 constructs and performed
a Rac1 activation affinity assay (Figure 2a; Supplementary Fig. 1). As expected,
overexpression of wildtype kalirin-7 induced approximately a fourfold increase in Rac1GTP levels compared to untransfected cells (Figure 2b). While overexpression of the
D1338N variant led to an increase in Rac1 activation as compared to the untransfected
condition, the degree of activation was significantly less than that induced by wildtype
kalirin-7. These results indicate that the D1338N kalirin-7 variant is impaired with respect to
the protein's ability to catalyze the exchange of GDP for GTP bound to Rac1.

Author Manuscript

As many of the downstream effectors of Rac1 are known to cause remodeling of the actin
cytoskeleton, we reasoned that a kalirin-7 variant that has impaired GEF activity would also
be less able to stimulate actin polymerization. We have previously shown that membrane
ruffling, a morphological indicator of actin polymerization, can be induced by expression of
either full length kalirin-7 protein or the kalirin-7 GEF domain alone14. Therefore, we
examined the effect of the D1338N variant on membrane ruffling in COS-7 cells (Figure
2c). The majority of cells expressing wildtype kalirin-7 exhibited membrane ruffling along
greater than 80% of their perimeters, representing a significantly greater degree of actin
polymerization than that induced by kalirin-7-D1338N (Figure 2d). Thus, the kalirin-7D1338N variant's diminished capacity for Rac1 activation has functional consequences in
the context of cytoskeletal reorganization.
Neuronal morphology in kalirin-7-D1338N expressing neurons

Author Manuscript

The processes of dendritic spine maturation, excitatory synapse potentiation, and de novo
spine formation are all dependent on remodeling of the actin cytoskeleton3, 28. The
requirement of kalirin-7 in regulating these processes in forebrain pyramidal neurons has
been well established11, 13. As such, we sought to determine whether the D1338N
substitution would impair kalirin-7's ability to promote spine growth and development
(Figure 3a). In mature cortical pyramidal neurons (21-28 DIV), overexpression of kalirin-7D1338N failed to enhance spine density and area, whereas wildtype kalirin-7 overexpression
increased both spine parameters (Figure 3b). These data indicate that the D1338N variant
not only impacts kalirin-7 protein function, but also has severe effects on spine structural
plasticity.
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Spine morphology is thought to contribute to brain neuropil volume, and post-mortem
analyses and structural MR imaging studies of the brains of patients have provided evidence
for reduced spine density and cortical thickness in the prefrontal and auditory association
cortices in schizophrenia. To explore whether the subjects carrying the kalirin-7-D1338N
variant displayed unique neuromorphometric features, we compared MRI measures of
cortical thickness between the carrier subjects and non-carriers. This preliminary
comparison suggested that both the subject with schizophrenia (KAL-SCZ) and the sibling
with depression (KAL-SIB) had reduced cortical thickness in the posterior banks of the left
superior temporal sulcus (STS) as compared with the means of comparison groups of
schizophrenia subjects (SCZ), their unaffected siblings (SCZ-SIB), and control subjects
(CON) (Figure 4a, b).

Author Manuscript

Thinner cortex in Kalrn-deficient mice

Author Manuscript

Because a causal relationship cannot be established in this case, we sought to determine
whether reduced kalirin signaling in animal models could result in cortical morphological
phenotypes consistent with the neuroimaging human phenotypes. We have previously
reported that total knockout of the Kalrn gene in mice leads to reduced cortical thickness, as
measured in the frontal cortex18, 21. We therefore analyzed cortical neuropil area in the
secondary auditory and temporal association cortices of Kalrn heterozygote mice, which
better mimic the reduced kalirin signaling of the kalirin-7-D1338N variant (Figure 4c). We
labelled cell bodies by perfoming Nissl staining on coronal sections from 12-week-old mice,
and defined neuropil as the area of the tissue that was devoid of stain. Kalrn heterozygotes
exhibited a significant reduction in neuropil area as compared to wildtypes (Figure 4d) (92.4
± 0.8% of wildtype area). These data indicate the necessity of intact functional kalirin
expression for normal cortical morphology.

Discussion

Author Manuscript

Recent genomic studies have revealed extensive interindividual variability and diversity in
the human genome, including common and rare variants, missense and nonsense mutations,
and copy number variants29, 30. Genome-wide association and copy number variation
studies of schizophrenia and other psychiatric disorders have identified many new disease
susceptibility genes involving both common single nucleotide polymorphisms (SNPs) and
rare disease variants, most of which contribute small effects31. In addition, variations in a
number of genes have been associated with mental disorders such as schizophrenia32, 33. It
has been suggested that variations that increase risk for mental disorders cluster in gene
networks that controls the synapse development and plasticity34. However, few studies have
examined sequence variation in human genes encoding synaptic proteins, their molecular
and cellular functional consequences, and their potential impact on human brain
neuroimaging and phenotypes.
In the current study, we have established the presence of a rare KALRN sequence variant in
a patient-sibling pair, which results in a single amino acid change in the kalirin-7 protein's
catalytic GEF domain. Although we did not establish this variant as a risk for schizophrenia,
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it is predicted to be deleterious and present at a very low frequency in the human population.
Additionally, while the sibling carrying the variant did not present with schizophrenia, she
had been diagnosed with major depressive disorder, the treatment of which has been linked
to increased dendritic spine formation35. Pleiotropy is commonly seen in psychiatric
disorders and other complex traits (reviewed in Duan et al.31). A schizophrenia
susceptibility locus may be associated with not only other psychiatric disorders36, 37, but
also some other non-psychiatric disorders, such as multiple sclerosis38 and cardiovasculardisease39. Among psychiatric disorders, such shared genetic susceptibility may be due the
shared subphenotypes. Symptoms of mood disorder are common among individuals with
schizophrenia40, and they are also observed in their relatives at rates higher than those
observed in the general population. Additionally, in young adults, depression may be a
prodromal sign of psychosis41. Moreover, variations in clusters of genes, including KALRN,
implicated in schizophrenia and psychotic bipolar disorder etiology may impact resting state
functional activity in affected individuals and first-degree relatives. This attests to the impact
of common and rare genetic variation on measurable functional outcomes potentially related
to disease phenotypes42. One hypothesis for the minor allelic variant in KALRN would be
that this variant alters cortical thickness, a subphenotype that manifests as schizophrenia or
major depressive disorder depending on other genetic modifiers or different individual
genetic backgrounds.

Author Manuscript
Author Manuscript

At the cellular level the slightly altered protein affects phenotypes, particularly with regard
to dendritic spines, in a manner similar to that of kalirin-7 proteins that lack a functional
GEF domain15, as well as those which are incapable of being phosphorylated by upstream
signaling proteins17. Therefore, it stands to reason that altered function in proteins in the
kalirin-7 signaling pathway could also cause dendritic spine dysfunction, and, at the
anatomical level, cortical thinning. It has previously been shown that kalirin-7 interacts with
DISC119, and that it is a necessary component of pathways downstream of both NRG1/
ERBB4 and 5-HT2A serotonin receptors43, 44. DISC1 variants associated with
schizophrenia correlate with reduced cortical thickness in several regions independent of
psychiatric diagnosis45, 46. Knockdown of DISC1 in cultured cortical neurons also results in
diminished dendritic spine number19, and frontal cortex pyramidal neurons in mice carrying
DISC1 missense variants or truncations display reduced spine number and dendrite length
than those in wildtypes47, 48. Similarly, patients carrying a schizophrenia-associated minor
NRG1 allele have reduced superior temporal gyrus volumes as compared to patients
carrying the major allele49, and mice lacking CNS expression of Erbb2 and Erbb4 exhibit
reduced dendritic spine density in frontal cortex pyramidal neurons50. Furthermore, kalirin-7
has been shown to be essential for 5-HT2A receptor-induced dendritic spine growth44.
Antagonism of the 5-HT2A receptor is considered to be an important mechanism of the
action of atypical antipsychotic drugs51, and schizophrenic patients consistently exhibit
decreased levels of these receptors in several cortical regions52.
We have previously demonstrated that Kalrn null mice have decreased spine number and
dendritic arborization as compared to wild-types18, 21, and we show here that they have
thinner temporal association cortices. Interestingly, the human subjects carrying this variant
have a thinner cortex in the STS. The STS is part of a network that includes the medial
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prefrontal cortex and amygdala and is involved in aspects of social cognition, including
empathy and theory of mind. Patients show abnormal activation of this network during tasks
involving the rating of emotional valence in facial expression53, and flat affect item score is
negatively correlated with performance on these tasks54. While the scope of our analyses is
limited by statistical power and does not demonstrate a causal relationship between
p.D1338N and specific endophenotypes in carriers, our published and current data on Kalrn
knockout mice may fill in the gap to some extent. Mouse knockout data suggest a causal
relationship between reduced kalirin function and the regulation of both neuropil size and
cortical morphology18, 21. Since such morphological alterations are reminiscent of the
structural abnormalities seen in schizophrenic patients55, 56, the role of kalirin in regulating
cortical thickness in humans and animal models should be explored further.

Author Manuscript

During normal development, cortical pyramidal neurons undergo a period of synaptic
pruning during adolescence to refine connections before reaching a steady state level in
adulthood57. This pruning is exaggerated in schizophrenia, and diminished synaptic density,
along with less extensive dendritic arborization and smaller pyramidal neuron soma size, is
thought to be one of the cellular morphological changes responsible for the decreased
cortical gray matter observed in patients58, 59, 60. Post-mortem analyses of brains from
schizophrenia patients also demonstrate a reduction in the density of pyramidal neuron
dendritic spines in several regions of the cortex, including the dorsolateral prefrontal cortex,
the anterior cingulate cortex, and the superior temporal gyrus23, 61.

Author Manuscript

There are important caveats in this study. It should be noted that neither causality nor an
association between the p.D1338N variant and any particular phenotype are established in
this particular case, due to only two identified carriers. A more definitive test of association
would require a large population case-control sample. Nevertheless, our study is one of the
first to demonstrate that rare putatively deleterious variants in KALRN can lead to
phenotypic changes relevant to schizophrenia. Our results are significant in the context of
known supporting evidence for the association of both common and rare variants in KALRN
with schizophrenia. The most significant association of a common variant in KALRN in the
Psychiatric Genomics Consortium schizophrenia GWAS data set had a p-value of 5×10-462.
Although the associations of common KALRN variants with schizophrenia have not reached
genome-wide significance, they have been observed in other previous GWAS using
different ethnic samples63, 64. Resequencing KALRN in a Japanese sample further suggested
that rare (MAF<1%) putatively functional missense SNPs may also contribute to
schizophrenia risk22. Finally, the preliminary, uncorrected STS finding should be treated
with caution. The effect of KALRN on cortical thickness may be relatively weak therefore
requiring more subjects for increased statistical power.

Author Manuscript

It should be noted that there have been no single rare coding SNPs that are identified to
show a statistically significant association with schizophrenia, even in large exome
sequencing projects25, 26. This does not exclude the possibility that some rare functional
variants in certain genes do contribute to susceptibility, and intriguingly, rare coding
variants are found to be enriched in synaptic genes25, 26. Our study focuses on the
functionality of the KALRN gene and one of its variants, rather than association evidence.
We have shown that relationships could in principle be drawn between rare genetic sequence
Nat Commun. Author manuscript; available in PMC 2015 March 16.
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variants and neuroimaging and diagnostic phenotypes, given the appropriate number of
subjects. Knowledge about the cellular and circuit-level impact of rare genetic variants in
human subjects may in future point to disease mechanisms: specific molecular domains or
functions, such as enzymatic domains, protein-protein interaction motifs, or phosphorylation
sites, affected by amino acid changes could provide clues to the downstream/upstream
members of the pathway.
When done at a suitable scale, this approach may provide insight into the pathogenesis of
mental disorders. The approach we have taken could be a blueprint for larger scale studies
that combine human genetics, cellular and molecular analysis of impact of mutations, and
analysis of cognitive, behavioral, and neuromorphometric measures in carriers.

Methods
Author Manuscript

Human subjects

Author Manuscript

Study participants were recruited through the Conte Center for the Neuroscience of Mental
Disorders (CCNMD) at Washington University in St. Louis. Participants included
individuals with schizophrenia based on Diagnostic and Statistical Manual of Mental
Disorders, Ed IV (DSM-IV-TR) criteria (n = 127), and their non-affected siblings and
healthy control participants (n = 246). A subset of these participants also elected to undergo
structural MR imaging; their demographic information is as follows: patients (SCZ), n = 33,
9 females and 24 males, mean age of 24.3 ± 4.0 years; siblings (SCZ-SIB), n = 40, 20
females and 20 males; mean age of 23.6 ± 3.7 years; and controls (CON), n = 25, 11 females
and 14 males, mean age of 20.3 ± 4.9 years. Details of the recruiting process are discussed
elsewhere65, 66. All patients provided signed consent, and all activities and procedures were
approved by the Washington University in St. Louis Institutional Review Board.
Genomic DNA sequencing
PCR amplification of KALRN exons 23-28 and adjacent intronic regions from genomic
DNA samples from 127 individuals with schizophrenia and 246 siblings and controls,
followed by resequencing and automated indel/SNP analysis, was performed by Beckman
Coulter Genomics (Danvers, Massachusetts) on an ABI3730 capillary sequencer. PCR
primer sequences are listed in Supplementary Table 3.
Primary neuronal cultures

Author Manuscript

High density cortical neuron cultures were prepared from Sprague-Dawley rat E18 embryos
as described previously67. Pooled cortices were minced and cells were dissociated in a
papain solution containing DNAseI, L-cysteine, and EDTA (all from Sigma-Aldrich, St.
Louis, Missouri). Cells were further dissociated mechanically and then strained, followed by
counting of viable cells. Neurons were plated at a density of 3 × 105 cells per well onto
covers lips coated with poly-D-lysine (0.2 mg/ml, Sigma-Aldrich) in a 12-well plates, in
plating media (feeding media plus 5% fetal calf serum). After 1 hour, the media was
changed to feeding media (Neurobasal media supplemented with B27 (Life Technologies,
Grand Island, New York) and 0.5 mM glutamine). 200 μM D, L-amino-phosphonovalerate
(Abcam, Cambridge, Massachusetts) was added to the media 4 days later.
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The plasmid encoding myc-kalirin-7, generated by subcloning of rat kalirin-7 cDNA
pSCEP. Myc and then into pEAK10. His, was described previously14. The D1338N
kalirin-7 variant was created by site-directed mutagenesis using the QuickChange II XL
mutagenesis kit (Agilent Technologies, Santa Clara, California). The sequence of the
forward mutagenesis primer was 5′GGCAACATCCAAGAGATCTACAATTTCCATAACAACATC-3′. Cortical neurons
(DIV 24-26) were transfected with 4-6 μg of the appropriate cDNAs for 4 hours in
Neurobasal medium in the presence of Lipofectamine 2000 according to the manufacturer's
protocol.

Author Manuscript

COS-7 and hEK293 cells were grown to ∼40% confluency in Dulbecco's modified Eagle's
medium (DMEM) with 10% fetal bovine serum and penicillin/streptomycin. Cells were then
transfected with appropriate cDNAs in DMEM media without antibiotics or serum using
Lipofectamine 2000. Cells were transfected when they reached ∼40% confluency and were
∼95% confluent at the time of harvesting.
Rac1 activation assay
Transfected hEK293 cells were harvested when they reached ∼95% confluency. Active
Rac1 levels were assessed using a Rac1 Activation Assay Kit (Millipore, Billerica,
Massachusetts) following the manufacturers' protocol with normalization to total Rac1 as
described previously17. Antibodies against c-myc (1:500, Santa Cruz Biotechnology, Dallas,
Texas) and β-actin (1:4000, Sigma-Aldrich) were used to control for levels of exogenously
expressed protein. Blots were then analyzed with ImageJ68.

Author Manuscript

Membrane ruffling analysis
Analysis of membrane ruffling, a process induced by actin polymerization, was performed
in COS-7 cells expressing either wildtype or mutant myc-tagged kalirin-7. Following
fixation, cells were immunostainied with an anti-myc antibody (Santa Cruz), and F-actin
was visualized by incubation with Oregon Green 488-conjugated phalloidin (Life
Technologies). Cells expressing myc-tagged protein were imaged using a confocal
microscope (Zeiss LSM5 Pascal), and images were analyzed using ImageJ. A membrane
ruffle was defined as an actin-rich undulating membrane protrusion folding back from the
adherent surface of a cell.
Analysis of sequence variants in neurons

Author Manuscript

Quantitative analysis of spine number and morphology (area, breadth and length) in cortical
pyramidal neurons overexpressing the wildtype KALRN or its associated mutants was
performed using an approach we have described previously16, 17, 21, 44. Cortical neurons
cultured on coverslips of postnatal age DIV 24-26 (corresponding to adolescence) were
transfected with pEGFP-N2 (Clontech, Mountain View, California) to express green
fluorescent protein (GFP) to visualize cell morphology, either alone or together with myctagged kalirin-7 for 48 hrs. Neurons were then fixed and immunostained to visualize spine
morphology. Briefly, neurons were fixed with 4% formaldehyde in 4% sucrose/phosphate
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buffered saline (PBS), followed by ice cold methanol. After permeabilization and blocking
in a solution of 2% normal goat serum/0.1% Triton X-100/PBS, neurons were incubated
with an antibody against GFP (1:1000, Millipore), and an anti-myc antibody (1:1000, Santa
Cruz) to visualize myc-tagged kalirin-7. Neurons were then washed, incubated with AlexaFluor 488- and Alexa-Fluor 568-conjugated secondary antibodies, and mounted onto slides
with ProLong Gold Antifade mounting medium. Neurons transfected with the mutation
construct were compared to neurons expressing the wild type gene or GFP only. Expression
levels of exogenous protein were normalized to GFP, and only cells that express equal levels
of exogenous protein, with consistent subcellular targeting, were analyzed. Healthy neurons
expressing both GFP and myc-tagged protein were imaged using a 63× oil immersion
objective on a confocal microscope (Zeiss LSM5 Pascal). Z stacks of three to eight images,
averaged 4 times, were taken at 0.37 μm intervals, with a 1024 × 1024 pixel resolution at a
scan speed of 3 s per section. Cultures that were directly compared were stained and imaged
simultaneously. Following reconstruction of two-dimensional maximum projection images,
spines were manually outlined, and length, width, area, density were measured in
MetaMorph software (Molecular Devices, Sunnyvale, California) and subjected to statistical
analysis (Student's t test). For each condition, a 100 μm dendritic region from each of 10-20
neurons each from 3 experiments were analyzed.
Nissl staining of mouse brains

Author Manuscript

Mice carrying the Kalrn null mutation were generated by replacing exons 27 and 28 of the
Kalrn gene with a neo cassette, and have been described previously18, 21. Twelve-week-old
mice were anesthetized with a ketamine/xylazine mixture and perfused transcardially with
PBS followed by 4% paraformaldehyde (PFA) in PBS. Brains were removed, postfixed
overnight in 4% PFA/PBS, and cryoprotected in 30% sucrose/PBS. Brains were then
cryosectioned at 50 μm and mounted on slides. Slides were passed through a graded series
of ethanol solutions before being stained with a solution containing 0.625% cresyl violet
acetate and 0.375% acetic acid. Slides were then dehydrated and mounted with Permount
(Fisher Scientific, Pittsburgh, Pennsylvania).
Cortical neuropil analysis

Author Manuscript

Cortical neuropil in mice was quantified using semiautomatic image analysis. The temporal
association area from 5-6 Nissl-stained sections 300 μm apart between bregma -1.82 mm
and -3.40 mm, on either side of the midline, and were imaged with a 10× objective (NA
0.17, lateral resolution 0.633 μm/pixel). Analysis was performed remotely using ImageJ,
with the experimenter blind to conditions. Images of layer 2/3, 4, and 5 were first
thresholded to separate neurons from background. Because of possible variations in staining,
images were thresholded automatically on a per-image basis. Images were then made into
binary images, and glia were excluded by filtering objects smaller than 100 μm. The density
of neuronal cell bodies in each image was quantified for each genotype, and neuropil size
was defined as the percent of the area of each image not occupied by cell bodies. Both
hemispheres from 5-6 sections were analyzed from three to four mice per genotype.
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MR image collection and processing
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T1-weighted MPRAGE scans were collected on a Siemens 3T TIM TRIO imaging system
(Siemens Medical Systems, Malvern, Pennsylvania) with 1 mm × 1 mm × 1 mm resolution.
The MRI scans were processed with the Freesurfer (FS) image analysis suite release 4.1.069
(http://surfer.nmr.mgh.harvard.edu), which produced surface tessellations at the gray/white
matter interface and the gray/CSF interface. FS provided 72 cortical regions of interest
(ROI) based on a standard parcellation atlas70, along with measures of cortical gray matter
thickness (mm) for each of these regions using embedded FS algorithms.
Statistical analysis
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Differences between the KALRN-variant-bearing individual with schizophrenia (KALRNSCZ) and SCZ population were evaluated by generating standard (Z) scores for each cortical
parcellation on the cortical thickness. Significance was defined as p < 0.05. Due to the
exploratory nature of this analysis, scores were not corrected for multiple comparisons. Sign
tests were performed to determine the relative placement of the KALRN-SCZ raw score (xK)
in relation to the SCZ and CON mean values. Sign was evaluated by applying the following:

Where xK is the KALRN-SCZ raw score, and μSCZ and μCON are the schizophrenic and

Author Manuscript

control population means, respectively. If
, then sign = 1, denoting the
KALRN-SCZ value for that anatomical region and measure, xK, is further away from μCON
than μSCZ is from μCON in either the positive or negative direction. If
, then
sign = -1, which signified a value of xK that is closer to μCON than μSCZ is to μCON. As we
were interested in values of xK that were accentuations of the SCZ phenotype, i.e. deviations
from μCON in the extreme, we identified areas and measures of interest as those where p(xK)
< 0.05 and sign = 1.
This process was repeated to establish similar relationships between the KALRN-variantbearing sibling (KALRN-SIB) and the SCZ-SIB population.

Supplementary Material
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Identification of the KALRN variant coding for kalirin-7 p.D1338N. (a) Schematic of the
kalirin-7 protein (top), mRNA (middle), and the genomic regions that were sequenced. The
catalytic Rac1-GEF domain, composed of Dbl-homology (DH) and pleckstrin-homology
(PH) domains, is indicated. Fifteen distinct silent and intronic variants identified among 127
patients are denoted by black arrows, and the SNP leading to the p.D1338N variant is
denoted by a red arrow. (b) Chromatogram illustrating that KAL-SZ is heterozygous for the
minor allele (NC_000003.12:g.124462620G>A) responsible for the kalirin-7 coding variant.
The chromatogram from KAL-SIB showed a similar result.
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Figure 2.
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Biochemical consequences of the D1338N variant. (a, b) Activation of Rac1 is attenuated in
hEK-293 cells expressing kalirin-7-D1338N as compared to those expressing wildtype (WT)
kalirin-7. Rac1-GTP was isolated by incubation of cell lysates with a GST-PAK binding
domain fusion protein, and levels were normalized to total Rac1 and kalirin-7 expression.
Three independent experiments were performed, each of which involved transfection of two
wells of cells per condition. (c, d) COS-7 cells expressing myc-kalirin-7-D1338N (lower
panels) exhibit a lesser degree of membrane ruffling, as visualized by staining with
Alexa488-conjugated phalloidin, than do those expressing wildtype kalirin-7 (upper panels).
The cell in the upper left panel displays ruffles on nearly 100% of its perimeter, whereas the
cell in the lower left panel only displays ruffles in distinct locations (arrows). Analysis of
30-35 cells was performed for each condition. *: P < 0.05. Data are mean ± SEM. Scale bar:
10 μm.
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Figure 3.
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Dendritic spine density and area following kalirin-7 transfection. (a) Rat cortical pyramidal
neurons were transfected with an eGFP expression vector alone (top panel), or with wildtype
kalirin-7 (middle panel) or kalirin-7-D1338N (bottom panel). (b) Quantification of spine
density (upper panel) and spine area (lower panel) reveals an increase in both parameters in
the neurons overexpressing wildtype kalirin-7. No change was seen following
overexpression of kalirin-7-D1338N. *: P < 0.05; ***: P < 0.001. Data are mean ± SEM.
Scale bar: 5 μm.
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Figure 4.

Author Manuscript

Impact of kalirin-7 hypofunction on cortical thickness. (a, b) Both KAL-SCZ (red bar) and
KAL-SIB (blue bar) had reduced cortical thickness in the left superior temporal sulcus (STS;
location on pial and inflated surfaces illustrated in the upper and lower panels, respectively,
of (b)) as compared to the means of their respective experimental groups. The STS thickness
measurement for KAL-SCZ was 1.72 standard deviations lower than the SCZ group mean.
(c, d) Quantification of neuropil area in the temporal association cortex of 12-week-old
wildtype mice ((c), upper panels) and litter-matched heterozygous Kalrn-null mice ((c)
lower panels) revealed a reduction in neuropil in mice carrying only one functional Kalrn
allele. Neuropil was calculated by performing Nissl staining ((c), left panels), binarizing and
filtering images of the tissue ((c), right panels), and calculating the area of the images not
occupied by neuronal somata. Eight to twelve images were acquired from each of three or
four animals per genotype. ***: P < 0.001. Data are mean ± SEM. Scale bar: 100 μm.
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